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Introduction
The pharmaceutical industry has a growing need for
efficient analytical laboratories that can keep up with the
increasing workload generated by other areas within the
industry. The increased sample throughput and quick
turnover of analytical data are key factors for speedy new
product approval by regulatory agencies. To keep up
with the continuous increase in workload generated for
these laboratories, full automation is determined to be an
unavoidable task. This applies to instrumentation, com-
puters and data management, as well as to sample
preparation. Efficiency in chemical laboratories is greatly
improved by applying automated sample preparation
technology. Automated sample preparation via robotics
also improves safety and minimizes exposure ofpersonnel
to hazardous materials, which helps to achieve Good
Laboratory Practice (GLP).
The process of acquiring a laboratory robot may differ
from one organization to another. The first-time acquisi-
tion of a laboratory robot is the most critical, where the
outcome of the event will greatly affect future decisions.
Based on experience within New Brunswick facility, the
different stages of the decision-making process and the
start-up procedure of a laboratory robotic system are
discussed. Typical examples of various applications
within the pharmaceutical industry are presented.
The process of acquiring robotic system
The following is a list of the important issues to be
addressed during this process:
(1) Initial study.
(2) Justification.




After nearly 8 years since the introduction of robotic
technology, some laboratory personnel and managers still
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have doubts about the reliability of laboratory robots,
while many others have become more comfortable with
the technology and the degree of sophistication it
achieved. Laboratory robots have provided the means to
automate a variety of applications, especially within the
pharmaceutical industry. Robots, like many other sophis-
ticated instruments, are not 100% failure immune.
However, it is important to understand the causes in
order to minimize and prevent failures. Laboratory
robots provide, through successful applications, reliable,
accurate and cost-effective alternatives to manual opera-
tions. In a typical analytical laboratory, there are
conventional high-volume products and/or tests. These
are the ones that should be targeted first for automation.
Estimated cost savirigs may be calculated based on
manual preparation time, and the maximum number of
samples per analyst/shift versus robotic time and maxi-
mum number per 24 h period. An additional feature
would be a multi-application robot that can handle more
than one test. If there are not enough samples of one
application to keep the robot occupied 7 days a week, the
alternative will be to run accumulated samples for
application 1, then application 2 to follow and so on. The
length of the cycle will depend on the number ofsamples
for the particular application. Other factors that may be
considered during the initial study are: (i) the complexity
of the test, (ii) common steps that might be shared with
other applications, and (iii) environmental impact. The
conclusion of this stage should present a comparison of
current status, e.g. the total test hours, maximum number
of samples tested per shift, the overall retest rate, the
environmental aspects and safety ofpersonnel, versus the
proposed robotic operation.
Justification
The project leader should be dedicated, committed and
should understand the concept of laboratory automation
in order to communicate, troubleshoot and answer all
questions about the proposed applications.
The following are some guidelines to be considered
throughout the process of project justification.
The importance ofthe application to the short- and
long-term planning of the organization.
(2) The improved quality of testing.
(3) Increased productivity and efficiency.
(4) Cost effectiveness; most applications will offer a
pay back period of about 3-4 years.
(5) The possibility of using the proposed robotic
system to perform more than one test.
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(6) General cleanliness and better implementation of
GLPs.
(7) Safety of personnel from exposure to hazardous
chemicals and procedures.
(8) Are there other robots owned by the organization?
Who is the manufacturer and how successful they
are in their applications? This may create an
opportunity for exchange of valuable experience
within the organization.
The process ofselecting and designing the system
The system design and layout is a very critical step. This
includes thorough knowledge of the available modules
that duplicate the manual procedure. A perfect match is
often not possible, so certain alternatives should be
explored, e.g. redeveloping the analytical method,
approaching the vendor for possible manufacturing of
special hardware components. The following example
represents a typical study conducted for the recent
acquisition ofnew robot by chemical control department
at Bristol-Myers Squib, New Brunswick.
(1) A review of the manual analytical method will
serve as starting point for generating a list of
robotic modules to automate the method.
(2) A sketch of the bench-top layout plan will be used
to simulate the different steps of the application.
(3) Occasionally, a problem may arise due to the fact
that a custom-designed module is not yet available
on the market. These cases should be isolated and
addressed separately with the vendor for the
possibility ofspecial manufacturing and/or modifi-
cation of the method.
(4) Necessary information should be available about
the compatibility of existing equipment that might
be used to complement the robot.
(5) Initiation of technical discussions with vendors.
The outcome ofsuch communication should reflect
the best available hardware/software combination
to handle the subject application. A bench-top
layout should be finalized at the conclusion of this
stage. Also, a reliable estimate for the overall cost
of the robotic system and the necessary accessories
should be determined at this time. It is important
to understand that the total project budget would
be more than just the robot cost. Examples of the
extra cost related to the project: site preparation,
e.g. clean power line, sufficient outlets, adequate
utilities, waste disposal, inert gas supplies, remov-
ing or adding laboratory benches or tables, ad-
equate ventilation for quick removal of solvent
vapors, etc. The cost of programming the specific
application is always an option on top of the
purchase price, and the decision on that should be
made on a case-by-case basis depending on
available resources and funds.
This process of selecting a robot is quite lengthy
especially for new and/or very specialized applica-
tions. Extensive communications with vendors
proved to be very valuable during this period.
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Implementation stage
This process starts after the purchase order has been sent
out. Co-ordination between delivery of the robotic
hardware, developing application software, personnel
training, delivery of other instruments (e.g. HPLC, GC,
dissolution system) should be expedited and monitored
very closely. Appropriate timing in receiving all parts and
accessories are crucial for a successful start. Ifthe robot is
designed to perform simple routines, such as Karl Fischer
and weight variation, the start-up time and validation
process usually require less time than other complex
applications. As a guideline, for multi-application robotic
systems, it is recommended to start with the less complex
application, to complete it and start accumulating actual
savings early in the process. This also has some advan-
tage in boosting personnel morale and management
confidence.
Validation
The validation process should start right after complete
installation. Dry runs and real preliminary trials are
highly recommended. A validation protocol should be
approved by Quality Assurance or the regulatory author-
ity within the organization.
Based on the approved guidelines in the validation
protocol, the process should begin by challenging both
hardware and software robotic commands. Examples
may include alphanumeric inputs, proper sample and
standard sequence, balance accuracy, Master Lab Sta-
tion accuracy, solvent and column switching valve
selections, interface to laboratory information system and
data management, waterbath temperature, and proper
controlling of other equipments and peripherals. The
second stage of the initial validation may involve direct
comparison of manual versus robotic data. When the
final validation report is approved, the robotic system can
be used for routine testing. The validation should not stop
at the initial installation stage; all the critical parameters
of the application (e.g. solvent delivery, balance check,
vortexing time, ultrasonic bath efficiency, etc.) should be
checked periodically according to a well-established
schedule. It is probably a good idea to have a special
software program to perform critical parameters on
predetermined intervals where the mechanical moves and
other parameters can be checked by an analyst. Any
slight deviation of the preset parameters should be
corrected and revalidated immediately. A preventative
maintenance program is highly recommended.
Typical examples of robotic applications in phar-
maceutical laboratories
The following examples represent various applications
within the Bristol-Myers Squibb (BMS), New Bruns-
wick location.
The Zymate II system in figure is used by Quality
Control for tablet content uniformity testing. The system
can test five lots offour different cardiovascular products
(10 tablets each) in one single run. It is equipped with an
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Figure 1. A ZymateH robotic systemfor tablet content uniformity
testing by HPLC.
switching valve for automatic selection ofthe appropriate
condition for each chromatographic run ofeach product.
An additional second dilution step for higher potency is
automatically selected by the program when the appro-
priate product code is inputted. Sameday manual testing
of the four products would require four HPLC systems
equipped with auto samplers and four analysts to finish
the task ofone robotic run, which would require only one
person for half a day. The maximum capacity of the
automated system is five lots of any combination or
potency of the four products per run, after which a
manual intervention to reload the system is needed.
Figure 2 shows a multi-application system based on a ’PY
Technology’ robot by Zymark. The system is designed for
quality control (QC) testing ofvitamins and is capable of
performing liquid/liquid and solid/liquid extraction.
Each application run can handle up to 36 samples ofany
combination of solid or liquid multivitamin formulations
and raw materials. The generic design of this system is
very flexible because it offers automated sample prepara-
tion and analysis of a variety of pharmaceutical dosage
forms, e.g. solids, liquids, lotions, creams etc. If the
chemistry requires protecting sample components from
air, the system is equipped to purge each sample with
nitrogen during various stages of preparation. A wide
range of extracting temperatures is available through a
special circulated water or oil bath. The choice ofup to six
extracting solvents is also available through two master
lab stations.
Dissolution testing is becoming one ofthe most important
single parameter to monitor for regulatory authorities.
The volume of samples to be tested through various
stages of product development and for release testing
have increased the workload of analytical laboratories.
Manual dissolution is one of the most labour intensive
and tedious tasks in the pharmaceutical testing labora-
tory, especially for sustained, release formulations. This
situation is a tremendous burden for laboratory person-
nel. Automating this process is highly recommended and
should be one of the highest priorities for pharmaceutical
laboratory managers.
The earlier developments in automating sampling and
UV/HPLC analyses of some dissolution apparatus have
been recently evolved to the fully automated robotic
applications. The former apparatus consists of an IBM
PC which controls dissolution baths (up to 24 vessels),
delivery system and the UV/Vis spectrophotometer, or a
fraction collector to collect samples for HPLC finish. An
analyst is needed only to replace media and add samples
to the vessels. This system is currently used by the
Quality Control laboratory at the BMS New Brunswick
facility
Examples of robotic-controlled dissolution systems are
shown in figures 3 and 4. These are two of four systems
which are used by the Analytical R&D group to perform
dissolution of solid dosages. The systems are equipped
with options of using baskets or paddles. The robot
controls all the steps and parameters of a dissolution
testing, including cleaning vessels, changing media and
adding samples. Figure 5 shows the use of the robot to
analyse pharmaceutical products and metabolites in
biological fluids. In vivo bioavailability is an important
parameter during the product development stage.
The system shown in figure 6 is designed to serve the
radiopharmaceutical area. The parts of the robot that
handle radioactive material are clad with lead sheets. The
Figure 2. A Zymark PY Technology robotic system for HPLC
testing of multivitamin formulations.
Figure 3. A Zymark custom dissolution robot equipped with basket
application of UVfinish testing.
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Figure 4. A Zymark custom dissolution robot equipped withpaddle
application.
robot adds and mixes the radioactive diluent and injects
an aliquot into an HPLC system equipped with a gamma
counter detector. Figure 7 represents a system which is
used by the Quality Control laboratory for microbio-
logical assay of neomycin by turbidimetric technique.
The robot controls precise dilutions, additions, inocula-
tion and incubation at 37 C.
These successful applications are examples ofa continued
effort to automate laboratory functions within the BMS
pharmaceutical group.
Figure 5. A Zymark PY Technology robotfor testing ofbiological
samples.
Figure 6. A Zymark custom robotfor radiopharmaceutical testing.
Figure 7. A Zymark robotic systemfor microbiological testing.
The laboratories involved provide various analytical
services for chemical control, microbiological control,
and analytical research and development. The dramatic
increase in the number of robots in the New Brunswick
facility, from one robot first acquired by the Quality
Control department in 1985 to 22 by early 1990, is the
result of dedication, hard work and continuous effort to
face new challenges and new applications. This also
reflects the commitment ofBMS management to provide
customers with high quality and effective products.
Conclusion
The use of robots in analytical laboratories has been
expanded to automate various laboratory functions. In
order for laboratory managers to develop successful
applications and increase efficiency and productivity, a
few guidelines may be observed.
(1) Gaining the support and participation of labora-
tory personnel by demonstrating that expanding
robotic technology is not going to pose a direct
threat to their jobs. On the contrary, the new
technology should be presented as new opportun-
ities for advancement. It should be well known that
the human contribution and innovation for any
robotic applications will remain the main factor for
the overall success.
(2) Vendor responsibilities for maintenance, repair,
continuous updates ofexisting systems, and proper
communications to provide application support to
existing and future users will be the second most
important factor in expanding the use of labora-
tory robotics.
(3) A few members of laboratory personnel that still
doubt the reliability of laboratory robots should
seriously reconsider their standing. Automation
via robotics provides high-quality results including
precision with good reproducibility. Consistency of
everyday results is one of the most significant
outcomes of robotics. Other known benefits
include greater efficiency and productivity, high
sample throughput, safety and GLPs.
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